Search

Author/Creator Dean, Robert M.

1. A phase I trial of bortezomib in combination with everolimus for treatment of relapsed/refractory non-Hodgkin lymphoma. Issue 3 (4th March 2018)

Authors:
Hill, Brian T.; Smith, Mitchell R.; Shelley, Meredeth; Jagadeesh, Deepa; Dean, Robert M.; Pohlman, Brad; Sweetenham, John W.; Bolwell, Brian J.; Smith, Stephen D.
Journal:
Leukemia & lymphoma
Issue:
Volume 59:Issue 3(2018)
Page Start:
690
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Characterisation and prognostic impact of immunoparesis in relapsed multiple myeloma. (28th February 2020)

Authors:
Chakraborty, Rajshekhar; Rybicki, Lisa; Nakashima, Megan O.; Dean, Robert M.; Faiman, Beth M.; Samaras, Christy J.; Rosko, Nathaniel; Dysert, Hayley; Valent, Jason; Anwer, Faiz
Journal:
British journal of haematology
Issue:
Volume 189:Number 6(2020)
Page Start:
1074
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Dual institution experience of extranodal marginal zone lymphoma reveals excellent long‐term outcomes. (8th March 2016)

Authors:
Starr, Adam G.; Caimi, Paolo F.; Fu, PingFu; Massoud, Mira R.; Meyerson, Howard; Hsi, Eric D.; Mansur, David B.; Cherian, Sheen; Singh, Arun D.; Cooper, Brenda W.; De Lima, Marcos J.G.; Lazarus, Hillard M.; Gerson, Stanton L.; Jagadeesh, Deepa; Smith, Mitchell R.; Dean, Robert M.; Pohlman, Brad L...
Journal:
British journal of haematology
Issue:
Volume 173:Number 3(2016)
Page Start:
404
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Dual institution experience of nodal marginal zone lymphoma reveals excellent long‐term outcomes in the rituximab era. (22nd July 2016)

Authors:
Starr, Adam G.; Caimi, Paolo F.; Fu, PingFu; Massoud, Mira R.; Meyerson, Howard; Hsi, Eric D.; Mansur, David B.; Cherian, Sheen; Cooper, Brenda W.; De Lima, Marcos J. G.; Lazarus, Hillard M.; Gerson, Stanton L.; Jagadeesh, Deepa; Smith, Mitchell R.; Dean, Robert M.; Pohlman, Brad L.; Hill, Brian ...
Journal:
British journal of haematology
Issue:
Volume 175:Number 2(2016)
Page Start:
275
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Early stage, bulky Hodgkin lymphoma patients have a favorable outcome when treated with or without consolidative radiotherapy: potential role of PET scan in treatment planning. (13th July 2016)

Authors:
Nguyen, Van T.; Pophali, Priyanka A.; Tsai, Judy P.; Jagadeesh, Deepa; Dean, Robert M.; Pohlman, Brad; Morgan, David S.; Greer, John P.; Smith, Mitchell R.; Hill, Brian T.; Reddy, Nishitha M.
Journal:
British journal of haematology
Issue:
Volume 179:Number 4(2017)
Page Start:
674
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Outcomes and factors impacting use of axicabtagene ciloleucel in patients with relapsed or refractory large B-cell lymphoma: results from an intention-to-treat analysis. Issue 6 (12th May 2021)

Authors:
Mian, Agrima; Wei, Wei; Winter, Allison M.; Khouri, Jack; Jagadeesh, Deepa; Anwer, Faiz; Gerds, Aaron T.; Dean, Robert M.; Sobecks, Ronald; Pohlman, Brad; Hamilton, Betty K.; Majhail, Navneet S.; Hill, Brian T.
Journal:
Leukemia & lymphoma
Issue:
Volume 62:Issue 6(2021)
Page Start:
1344
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Progression with clinical features is associated with worse subsequent survival in multiple myeloma. Issue 4 (6th February 2019)

Authors:
Chakraborty, Rajshekhar; Liu, Hien D.; Rybicki, Lisa; Tomer, Jacqulyn; Khouri, Jack; Dean, Robert M.; Faiman, Beth M.; Kalaycio, Matt; Samaras, Christy J.; Majhail, Navneet S.; Valent, Jason
Journal:
American journal of hematology
Issue:
Volume 94:Issue 4(2019:Apr.)
Page Start:
439
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Risk of acute myeloid leukemia and myelodysplastic syndrome after autotransplants for lymphomas and plasma cell myeloma. (November 2018)

Authors:
Radivoyevitch, Tomas; Dean, Robert M.; Shaw, Bronwen E.; Brazauskas, Ruta; Tecca, Heather R.; Molenaar, Remco J.; Battiwalla, Minoo; Savani, Bipin N.; Flowers, Mary E.D.; Cooke, Kenneth R.; Hamilton, Betty K.; Kalaycio, Matt; Maciejewski, Jaroslaw P.; Ahmed, Ibrahim; Akpek, Görgün; Bajel, Ashish;...
Journal:
Leukemia research
Issue:
Volume 74(2018)
Page Start:
130
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Splenic marginal zone lymphoma: excellent outcomes in 64 patients treated in the rituximab era. Issue 7 (9th August 2017)

Authors:
Starr, Adam G.; Caimi, Paolo F.; Fu, PingFu; Massoud, Mira R.; Meyerson, Howard; Hsi, Eric D.; Mansur, David B.; Cherian, Sheen; Cooper, Brenda W.; De Lima, Marcos J.G.; Lazarus, Hillard M.; Gerson, Stanton L.; Jagadeesh, Deepa; Smith, Mitchell R.; Dean, Robert M.; Pohlman, Brad L.; Hill, Brian T...
Journal:
Hematology
Issue:
Volume 22:Issue 7(2017)
Page Start:
405
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗